Manejo obstétrico de la viruela símica en el embarazo

Abstract

Introduction: Monkeypox (Mpox) is a zoonotic disease caused by the monkeypox virus, which has mainly affected West and Central Africa since 1970. In May 2022, the first outbreaks of Mpox were detected outside these regions, with cases related to travel to Europe and North America. Objective: to establish the obstetric management of monkeypox in pregnancy. Methodology: A descriptive study is carried out in the following databases PubMed, Google Scholar; using key words, health descriptors such as "monkeypox" "monkeypox" "management of monkeypox" "pregnancy" from the last 5 years; preferably meta-analysis, analysis, case studies and systematic reviews in Spanish and English, choosing approximately 25 articles. Conclusion: Monkeypox (Mpox) is a growing global threat. In 2022, the WHO declared it an international public health emergency, despite its endemic origin in Africa. It is essential to increase awareness, improve diagnosis and strengthen disease prevention and control. Pregnant women are particularly vulnerable, and rapid adaptation to evolving knowledge and recommendations is required. Equitable access to treatments and vaccines for pregnant women must be guaranteed. Additionally, global collaboration on clinical trials is needed to evaluate the effectiveness and safety of antiviral medications in pregnancy.